Known prevention and treatment do not reach most people who die of cancer.
Why, and how we know
About half of cancer deaths trace to modifiable risks, and about 70% of deaths occur in low- and middle-income countries. The fixes are policy, machines, staff and drugs, which nobody profits from selling at scale. Binding choice is inference.
Wrong if: If modifiable risks explained well under a quarter of deaths, or survival gaps closed without new delivery, this is not binding.
Found: Looked for refutation. Found the opposite: ACS/IARC Cancer Atlas says about half of cancer deaths are attributable to modifiable risks; a 2026 WHO/IARC study puts 37.8% of new cases on modifiable risks. WHO AFRO says about 70% of cancer deaths are in LMICs. Weak point: the "half" figure is from an ACS-led atlas, and attribution is not the same as deaths avoidable in practice.
On it: WHO Global Initiative for Childhood Cancer, IAEA Rays of Hope, St. Jude Global
ASCO Post: nearly 50% of cancer deaths attributable to modifiable risks (Cancer Atlas) · ASCO Post: WHO/IARC analysis, 37.8% of cases attributable to modifiable risks (Feb 2026) · WHO AFRO: cancer
Tobacco still causes about one in five cancer deaths, and 1.2 billion people use it.
- WorkWrite a one-page brief on tobacco tax levels for one country where use is rising.
- FundGive to a tobacco control program in a country where absolute user counts are growing.
Why, and how we know
Tobacco use fell 27% since 2010, short of the 30% WHO target. Users in Africa are still rising with population growth. The levers are taxes and laws, which take politics, not science.
Wrong if: If tobacco-attributable cancer deaths fell sharply without further policy change, this would not be a live constraint.
Found: WHO October 2025 report: 1.38B users in 2000 to 1.2B in 2024; prevalence 33.1% to 19.5%; projected over 1.15B by 2030. Decline is real but slow. The "one in five cancer deaths" figure is from the Cancer Atlas, not a WHO death count; WHO/IARC gives 15.1% of new cases from smoking.
On it: WHO
WHO tobacco trends report, 6 Oct 2025 · ACS Cancer Atlas: risk factors
Children with cancer survive about 80% in rich countries and about 20 to 30% elsewhere.
- FundFund one year of essential childhood cancer drugs for a single named hospital partner.
- RunHelp one pediatric oncology unit set up a basic cancer registry to count outcomes.
Why, and how we know
More than 20 African countries have no radiotherapy at all. Pathology, drugs and trained staff are missing together. WHO targets 60% childhood survival by 2030, which means the gap is still open.
Wrong if: If LMIC childhood survival already approached 60% broadly, or radiotherapy gaps were closed, this child would shrink.
Found: UICC: about 80% five-year survival in high-income countries; WHO-linked sources say 20 to 30% in LMICs, St. Jude says about a third. A 2019-data study of 197 countries found no low- or lower-middle-income country at 60% at baseline. IAEA says more than 20 African countries lack radiotherapy; the exact current count was not found.
On it: WHO Global Initiative for Childhood Cancer, IAEA Rays of Hope, St. Jude Global
UICC: Global Initiative for Childhood Cancer · St. Jude: Global Initiative · IAEA Rays of Hope story · IAEA/WHO joint statement on Rays of Hope